RIGEL PHARMACEUTICALS INC 4

EVP/GC/CCO/Corporate Secretary Raymond J. Furey had 877 Rigel Pharmaceuticals common shares withheld at approximately $47.50 per share in a compensation-related Form 4 code F transaction, leaving him with 50,559 shares owned directly.

On September 1, 2026, Raymond J. Furey, EVP, General Counsel, Chief Compliance Officer and Corporate Secretary of Rigel Pharmaceuticals, Inc., had 877 shares of common stock withheld in a Form 4 code "F" transaction, representing shares surrendered to cover tax obligations (or similar) in connection with equity compensation at an implied price of $47.50 per share. Following this routine compensation-related withholding, Furey directly owned 50,559 shares of Rigel common stock, which includes 500 shares acquired under the issuer’s stock purchase plan. The transaction reflects a non-open-market disposition tied to equity awards rather than an open-market purchase or sale, and does not indicate an independent investment decision in the company’s stock.

Filing Facts

CIK

1034842

Ticker

RIGL

Form

4

Source Type

fda

Accession

0000905148-26-004077

Alert Tier

5